Search

Your search keyword '"Helen Hanson"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Helen Hanson" Remove constraint Author: "Helen Hanson"
101 results on '"Helen Hanson"'

Search Results

1. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

2. Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol

3. ‘A good decision is the one that feels right for me’: Codesign with patients to inform theoretical underpinning of a decision aid website

4. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

6. Development of an international glossary for clinical guidelines collaboration

7. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY)

9. Medication work among nonagenarians: a qualitative study of the Newcastle 85+ cohort participants at 97 years old

10. Living Film Histories: Researching at the Bill Douglas Cinema Museum

11. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis

12. UK recommendations forSDHAgermline genetic testing and surveillance in clinical practice

13. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

14. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

16. Reclassification of clinically-detected sequence variants:Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)

17. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes

18. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

19. Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group

20. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

21. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in

22. Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service

23. Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial

24. Transitions between frailty states in the very old: the influence of socioeconomic status and multi-morbidity in the Newcastle 85+ cohort study

25. Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network

26. Looking for Lela Simone: Singin’ in the Rain and microhistories of women’s sound work behind the scenes and below-the-line in Classical Hollywood Cinema

28. Surgical decision making in premenopausal BRCA carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a Qualitative Study

29. Cancer Risks Associated With

30. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

32. UK recommendations for

33. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants

34. Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes

35. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

37. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

39. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

40. 507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study

41. Surgical decision making in premenopausal

42. UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants

43. Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic

44. Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations

45. Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: A case-controlled study (SIGNIFY)

46. UKCGG Consensus Group guidelines for the management of patients with constitutional

47. Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in RAD51C and RAD51D

48. Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services

49. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

50. EP1229 Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR) study

Catalog

Books, media, physical & digital resources